In addition, the effects of Pimavanserin on the expression level of Claudin 5 and endothelial permeability were both abolished by the knockdown of KLF6, indicating that the protective effect of Pimavanserin in cerebral ischemia injury is mediated by KLF6. The gene discussed is CLDN5; the disease is Cerebral ischemia.